Randomized assessment of rapid endovascular treatment of ischemic stroke

New England Journal of Medicine

Volumn 372, Issue 11, 2015, Pages 1019-1030

  Goyal, Mayank ^a,c   Demchuk, Andrew M ^a,c   Menon, Bijoy K ^a,c   Eesa, Muneer ^a   Rempel, Jeremy L ^d   Thornton, John ^d   Roy, Daniel ^f   Jovin, Tudor G ^d   Willinsky, Robert A ^h   Sapkota, Biggya L ^t   Dowlatshahi, Dar ^k   Frei, Donald F ^v   Kamal, Noreen R ^a,c   Montanera, Walter J ⁱ   Poppe, Alexandre Y ^f   Ryckborst, Karla J ^a   Silver, Frank L ^h   Shuaib, Ashfaq ^e   Tampieri, Donatella ^g   Williams, David ^d,o,p   Bang, Oh Young ^w   Baxter, Blaise W ^u   Burns, Paul A ^z   Choe, Hana ^r   Heo, Ji Hoe ^x   Holmstedt, Christine A ^aa   Jankowitz, Brian ^q   Kelly, Michael ^l   Linares, Guillermo ^s   Mandzia, Jennifer L ^m   Shankar, Jai ⁿ   Sohn, Sung Il ^y   Swartz, Richard H ^j   Barber, Philip A ^a,c   Coutts, Shelagh B ^a,c   Smith, Eric E ^a,b,c   Morrish, William F ^a   Weill, Alain ^f   Subramaniam, Suresh ^a   Mitha, Alim P ^a,c   Wong, John H ^a,c   Lowerison, Mark W ^a   Sajobi, Tolulope T ^b   Hill, Michael D ^c   more..

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d Montreal Neurological Institute ^*  (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h TORONTO WESTERN HOSPITAL   (Canada)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^k UNIVERSITY OF OTTAWA   (Canada)

^l UNIVERSITY OF SASKATCHEWAN   (Canada)

^m LONDON HEALTH SCIENCES CENTRE   (Canada)

ⁿ DALHOUSIE UNIVERSITY   (Canada)

^o BEAUMONT HOSPITAL   (Ireland)

^p ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^q UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^r ABINGTON MEMORIAL HOSPITAL   (United States)

^s TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

^u Erlanger Hospital   (United States)

^v Colorado Neurological Institute   (United States)

^w Samsung Medical Center   (United States)

^x Yonsei University College of Medicine   (South Korea)

^y Dongsan Medical Center   (South Korea)

^z ROYAL VICTORIA HOSPITAL   (United Kingdom)

^aa MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS THROMBECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT RESPONSE; VERY ELDERLY; WORKFLOW; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEVICES; DIGITAL SUBTRACTION ANGIOGRAPHY; INTENTION TO TREAT ANALYSIS; MULTIMODALITY CANCER THERAPY; RADIOGRAPHY; REPERFUSION; SINGLE BLIND PROCEDURE; STENT; STROKE; THROMBECTOMY;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COMBINED MODALITY THERAPY; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; REPERFUSION; SINGLE-BLIND METHOD; STENTS; STROKE; THROMBECTOMY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84924691962     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1414905     Document Type: Article

References (44)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929-35.
3. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893-903.
4. [Erratum, N Engl J Med 2013;368:1265.]
5. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11-20.
6. [Erratum, N Engl J Med 2015;372:394.]
7. Del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
8. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: realworld experience and a call for action. Stroke 2010;41:2254-8.
9. Zeumer H, Hacke W, Ringelstein EB. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol 1983;4:401-4.
10. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke - the PROACT II study: a randomized controlled trial. JAMA 1999;282:2003-11.
11. Ciccone A, Valvassori L. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368:2433-4.
12. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368:914-23.
13. Demchuk AM, Goyal M, Yeatts SD, et al. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology 2014;273:202-10.
14. Menon BK, D'Esterre CD, Qazi EM, et al. Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke. Radiology 2015 January 29 [Epub ahead of print].
15. Von Kummer R, Meyding-Lamadé U, Forsting M, et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 1994;15:9-15.
16. Yoo AJ, Chaudhry ZA, Nogueira RG, et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke 2012;43:1323-30.
17. Goyal M, Almekhlafi MA, Fan L, et al. Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Circulation 2014;130:265-72.
18. Menon BK, Almekhlafi MA, Pereira VM, et al. Optimal workflow and processbased performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR Thrombectomy for Acute Revascularization study. Stroke 2014;45:2024-9.
19. Saver JL, Jahan R, Levy EI, et al. Solitaire Flow Restoration Device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-9.
20. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231-40.
21. [Erratum, Lancet 2012;380:1230.]
22. Pereira VM, Gralla J, Davalos A, et al. Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke 2013;44:2802-7.
23. Demchuk AM, Goyal M, Menon BK, et al. Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke 2014 December 25 (Epub ahead of print).
24. Goyal M, Shamy M, Menon BK, et al. Endovascular stroke trials: why we must enroll all eligible patients. Stroke 2013;44:3591-5.
25. Zhao W, Hill MD, Palesch Y. Minimal sufficient balance - a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Stat Methods Med Res 2012 January 26 (Epub ahead of print).
26. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000;355:1670-4.
27. [Erratum, Lancet 2000;355:2170.]
28. Puetz V, Dzialowski I, Hill MD, Demchuk AM. The Alberta Stroke Program Early CT Score in clinical practice: what have we learned? Int J Stroke 2009;4:354-64.
29. Nambiar V, Sohn SI, Almekhlafi MA, et al. CTA collateral status and response to recanalization in patients with acute ischemic stroke. AJNR Am J Neuroradiol 2014;35:884-90.
30. Von Kummer R, Bourquain H, Bastianello S, et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 2001;219:95-100.
31. Demchuk AM, Menon B, Goyal M. Imaging-based selection in acute ischemic stroke trials - a quest for imaging sweet spots. Ann N Y Acad Sci 2012;1268:63-71.
32. Parsons MW, Christensen S, McElduff P, et al. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010;30:1214-25.
33. Elm JJ, Palesch Y, Easton JD, et al. Screen failure data in clinical trials: are screening logs worth it? Clin Trials 2014;11:467-72.
34. Lindsay P, Bayley M, Hellings C, Hill M, Woodbury E, Phillips S. Canadian best practice recommendations for stroke care (updated 2008). CMAJ 2008;179: Suppl: S1-S25.
35. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.
36. Hong KS, Saver JL. Quantifying the value of stroke disability outcomes: WHO Global Burden of Disease Project disability weights for each level of the modified Rankin Scale. Stroke 2009;40:3828-33.
37. Khatri P, Yeatts SD, Mazighi M, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol 2014;13:567-74.
38. Sun CH, Nogueira RG, Glenn BA, et al. "Picture to puncture": a novel time metric to enhance outcomes in patients transferred for endovascular reperfusion in acute ischemic stroke. Circulation 2013;127:1139-48.
39. Goyal M, Menon BK, Hill MD, Dem Chuk A. Consistently achieving computed tomography to endovascular recanalization <90 minutes: solutions and innovations. Stroke 2014;45(12):e252-e256.
40. Almekhlafi MA, Eesa M, Menon BK, Demchuk AM, Goyal M. Ultrashort imaging to reperfusion time interval arrests core expansion in endovascular therapy for acute ischemic stroke. J Neurointerv Surg 2013;5: Suppl 1:i58-i61.
41. Sun CH, Ribo M, Goyal M, et al. Doortopuncture: a practical metric for capturing and enhancing system processes associated with endovascular stroke care, preliminary results from the rapid reperfusion registry. J Am Heart Assoc 2014;3(2):e000859.
42. Molina CA, Alvarez-Sabín J, Montaner J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002;33:1551-6.
43. Bradley EH, Curry LA, Webster TR, et al. Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems. Circulation 2006;113:1079-85.
44. Krumholz HM, Herrin J, Miller LE, et al. Improvements in door-to-balloon time in the United States, 2005 to 2010. Circulation 2011;124:1038-45.